MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-12-2026
Health Catalyst Total Assets 2011-2026 | HCAT
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Health Catalyst
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 503 M | 859 M | 702 M | 752 M | 832 M | 578 M | 302 M | 111 M | 110 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 859 M | 110 M | 528 M |
Quarterly Total Assets Health Catalyst
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 587 M | 616 M | 892 M | 859 M | - | - | - | 713 M | 752 M | - | - | 825 M | 832 M | 846 M | 563 M | 571 M | 578 M | 578 M | 578 M | 578 M | 302 M | 302 M | 302 M | 302 M | 111 M | 111 M | 111 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 892 M | 111 M | 541 M |
Total Assets of other stocks in the Health information services industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
476 M | - | 0.29 % | $ 206 M |  USA |
 |
Change Healthcare
CHNG
|
9.93 B | - | - | $ 9.03 B | USA |
 |
Phreesia
PHR
|
370 M | $ 11.2 | -0.8 % | $ 611 M | USA |
 |
Cerner Corporation
CERN
|
7.43 B | - | - | $ 27.9 B | USA |
 |
American Well Corporation
AMWL
|
324 M | $ 5.71 | -0.7 % | $ 91.6 M | USA |
 |
Computer Programs and Systems
CPSI
|
434 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
3.41 B | - | - | $ 2.94 B | USA |
 |
iCAD
ICAD
|
37.5 M | - | - | $ 102 M | USA |
 |
Schrödinger
SDGR
|
726 M | $ 11.42 | -1.3 % | $ 839 M | USA |
 |
Castlight Health, Inc.
CSLT
|
167 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
1.33 B | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
1.97 B | - | - | $ 6.37 B | USA |
 |
NextGen Healthcare
NXGN
|
644 M | - | - | $ 1.6 B | USA |
 |
Teladoc Health
TDOC
|
2.86 B | $ 5.59 | 3.23 % | $ 985 M | USA |
 |
1Life Healthcare
ONEM
|
2.63 B | - | - | $ 3.37 B | USA |
 |
Premier
PINC
|
3.1 B | - | - | $ 2.33 B | USA |
 |
Omnicell
OMCL
|
2.12 B | $ 34.87 | 1.19 % | $ 1.61 B | USA |
 |
OptimizeRx Corporation
OPRX
|
183 M | $ 7.22 | 6.42 % | $ 124 M | USA |
 |
Evolent Health
EVH
|
1.82 B | $ 2.27 | 0.44 % | $ 213 M | USA |
 |
MTBC
MTBC
|
87.6 M | - | -0.58 % | $ 51.7 M | USA |
 |
GoodRx Holdings
GDRX
|
1.39 B | $ 2.06 | 0.98 % | $ 795 M | USA |
 |
SCWorx Corp.
WORX
|
6.35 M | $ 0.13 | 3.31 % | $ 190 K | USA |
 |
Signify Health
SGFY
|
1.74 B | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
1.45 B | - | - | $ 3.81 B | USA |
 |
Akerna Corp.
KERN
|
7.63 M | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
2.43 B | - | -10.39 % | $ 886 M | USA |
 |
Zhongchao
ZCMD
|
25.9 M | $ 1.85 | 2.16 % | $ 9.63 M |  China |
 |
HealthStream
HSTM
|
511 M | $ 21.13 | 0.76 % | $ 642 M | USA |
 |
NantHealth
NH
|
160 M | - | -46.64 % | $ 10.4 M | USA |
 |
HealthEquity
HQY
|
3.38 B | $ 82.18 | 0.1 % | $ 7.08 B | USA |
 |
10x Genomics
TXG
|
965 M | $ 20.69 | 4.42 % | $ 2.42 B | USA |
 |
Streamline Health Solutions
STRM
|
35.6 M | - | - | $ 21.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
384 M | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
607 M | $ 17.8 | -1.41 % | $ 1.53 B | USA |
 |
So-Young International
SY
|
2.74 B | $ 3.15 | 8.08 % | $ 250 M | China |
 |
Veeva Systems
VEEV
|
8.98 B | $ 178.12 | -0.56 % | $ 29.2 B | USA |